Tan JT, McLennan SV, Williams PF, Rezaeizadeh A, Lo LW, Bonner JG, Twigg SM. Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model.
ADIPOSE TISSUE ACCUMULATION, which develops secondary to excessive caloric intake, is linked to the development of insulin resistance and is one of the characteristics of the metabolic syndrome. Dietary-induced animal models of obesity have been widely used to provide an in vivo insight into the development of adipose depots and insulin resistance. These dietary-induced models have the advantage over traditional genetic and knockout models in that they more accurately reflect the etiology of human type 2 diabetes mellitus, being mixed environmentally and polygenically rather than monogenically (36) . The C57BL/6 mouse is commonly used for these studies (14) , because when it is fed a diet high in fat it develops obesity, hyperinsulinemia, insulin resistance, and hypertension, all features characteristic of the metabolic syndrome (12, 53) . Furthermore, obesity in these animals is characterized by selective deposition of fat in the mesentery. This pattern of fat deposition models abdominal obesity in humans and is known to be an independent risk factor for the development of diabetes and cardiovascular disease (42, 52) . Additionally, with increasing obesity, high-fat-fed mice develop adipocyte hyperplasia and hypertrophy, commonly resulting in a fat mass increase of ϳ93% (6) .
Connective tissue growth factor (CTGF) also known as CCN-2, is a heparin-binding 36-to 38-kDa cysteine-rich peptide that is a member of the highly conserved CCN early response gene family of peptides (1, 2, 15, 20, 27) . It is a multifunctional protein produced by a variety of cells, including endothelial cells, fibroblasts, cartilaginous cells, smooth muscle cells, and fat cells (16, 24, 25, 27, 28, 41, 54) . We have shown previously that, like TGF-␤1, CCN-2 is downregulated during adipocyte differentiation in vitro, and in this system exogenously added CTGF was effective in the inhibition of the adipocyte differentiation program (55) . Our initial observations in chow-fed mice also showed that CCN-2 expression was twofold higher in the epididymal fat depot compared with the subcutaneous fat depot (55) . Because a lower level of differentiation of fat cells in the epididymal depot was associated with the development of insulin resistance, the higher basal expression of CCN-2 at this site implicated a possible role for this protein in the negative regulation of adipocyte differentiation in vivo (55) .
For adipogenesis to occur, mesenchymal precursor cells driven via a complex series of transcriptional events commit to becoming preadipocytes and either stay dormant or differentiate to mature adipocytes (14, 57) . This differentiation process is dependent on increased expression of transcription factors C/EBP␣ and peroxisome proliferator-activated receptor-␥ (PPAR␥). The increased C/EBP␣ and PPAR␥ then induce expression of proteins that are involved in lipid uptake and storage, and insulin sensitivity and the adipocyte undergo terminal differentiation (8, 23, 58, 62) . Adipocyte differentiation is also dependent on reorganization of the extracellular matrix, a process mediated by the matrix metalloproteinase (MMP) system. The regulator of MMP activities, tissue inhibitor metalloproteinase-1 (TIMP-1), has been studied in this regard and has been shown to be induced in adipose tissue of obese mice and humans (26, 32) . Furthermore, in vitro studies have shown that TIMP-1 is a negative regulator of adipocyte differentiation (10) , as is the other main inhibitor of tissue proteases, plasminogen activator inhibitor type 1 (PAI-1). We have shown previously, albeit in another mesenchymal cell type, that CCN-2 regulates TIMP-1 expression (33), but whether this relationship is also seen in vivo remains to be determined. PAI-1 is also induced by CCN-2 (61) in some cells, and it decreases during adipocyte differentiation and can cause insulin resistance (5, 18, 30, 59 ). In humans, PAI-1 concentration in the circulation is increased with obesity and correlates with various metabolic syndrome-associated measurements, such as waist-to-hip ratio and direct measurements of visceral fat (46, 49) .
Here, we investigate the expression of CCN-2 in both subcutaneous and epididymal fat in a dietary-induced murine model of obesity. The relationship between fat depot CCN-2 expression, cell size, and differentiation marker expression, as well as the negative regulators of differentiation in the development of obesity and insulin resistance, was also investigated.
MATERIALS AND METHODS
Dietary-induced mouse model of obesity. Six-week-old male C57BL/6 mice used in this study were purchased from ARC (Perth, Australia) and were fed for Յ24 wk ad libitum on either standard laboratory chow (ND) and water or a diet high in fat and fructose (HFD). The study was approved by the Animal Ethics Committee of Sydney South West Area Health Services, Australia. The diet consisted of food containing 45% kcal of fat, 20% kcal of protein, and 35% kcal of carbohydrate (D12451; Research Diets, New Brunswick, NJ), and animal drinking water was supplemented with 5% (wt/vol) fructose. All animals were weighed at the beginning of the experiment and weekly for either 15 or 24 wk. At weeks 15 and 24 of dietary intervention, insulin tolerance tests (ITTs) were performed. Mice had 48 h to recover from the ITT and were then anesthetized with ketamine (85 mg/kg body wt) prior to termination by exsanguination. Adipose tissue from two fat depots, the gonadal-associated (i.e., epididymal) fat and subcutaneous fat, was thoroughly excised and weighed. The subcutaneous fat was derived from the site just above the pelvis bilaterally in the subcutaneous tissue plane. Portions of tissue from each fat site were snap-frozen in liquid nitrogen or optimal cutting temperature media (TissueTek; Sakura Finetek, Torrance, CA) and then stored at Ϫ80°C for later RNA and protein extraction. Other portions of fat from these sites were fixed in 4% paraformaldehyde for 24 h and then 70% ethanol prior to paraffin embedding. Liver tissue was also excised and weighed.
To determine whether the HFD affected insulin sensitivity, an ITT was performed according to standard methods (3, 9, 60) . In brief, mice were fasted overnight prior to an intraperitoneal injection of human insulin (Actrapid) at a dose of 0.75 IU/kg body wt. Blood glucose levels were monitored at 0, 5, 15, 30, and 60 min post-insulin administration from 10 l of whole blood using a point of care blood glucose monitoring system (Accu-Check Advantage; Roche Diagnostics). The excursion in blood glucose level over time was plotted and the insulin sensitivity was calculated as the inverse of the area under the curve (AUC).
Measurement of adipose tissue gene expression. To examine the effect of HFD on gene expression of CCN-2 and markers of adipocyte differentiation PPAR␥ and adiponectin, along with genes involved in tissue turnover TIMP-1 and PAI-1, RNA was extracted from 100 mg of adipose tissue using Qiagen's RNeasy Lipid Tissue Mini Kit (Qiagen, Valencia, CA). The RNA concentration and quality was determined using the SmartSpec Plus Spectrophotometer (Bio-Rad) and was between 1.70 and 1.90 in every case. Total RNA (2 g) was reverse transcribed to cDNA using 10 pmol of oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen, Carlsbad, CA) and SuperScript III Reverse Transcriptase (Invitrogen). The mRNA expression of the various genes was determined by quantitative real-time PCR using Platinum Quantitative PCR Supermix-UDG (Invitrogen) and 20 pmol each of forward and reverse primer. Primer sequences are listed in Table 1 , and the PCR conditions were as described previously (55) . For CCN-2, a plasmid standard curve ranging from 10 3 to 10 9 copies was run with the samples and the copy number of amplicons determined from the generated standard curve.
Measurement of adipocyte CCN-2 protein.
The expression and localization of CCN-2 in the fat depots was determined by Western immunoblot and immunohistochemistry. For the Western immunoblots, protein was extracted from 200 mg of adipose tissue homogenized with lysis buffer (20 mM Tris·HCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 1.5 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin, 1 mM sodium orthovanadate, and 0.2% Triton X-100, pH 7.4). Samples were then resolved on SDS-PAGE using 12.5% separation gels and 4% stacking gels in running buffer (3 g of Tris, 14.4 g of glycine, and 10 g of SDS), and each lane was loaded with the same amount of total protein [40 g for epididymal fat and 50 g for subcutaneous fat, determined using the Bio-Rad DC Protein Assay (Bio-Rad, Richmond, CA)]. CCN-2 protein was detected using antisera for the carboxy-terminal of CCN-2 (196, 1:1,000 dilution) generated in-house, as described previously (56) . Bands were visualized using a horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) and chemiluminescence (Amersham Biosciences, Piscataway, NJ). The protein ␣-tubulin was used as a loading control and was detected using an ␣-tubulin antibody (ab 40742; Abcam) and visualized using a goat-anti-rabbit HRP secondary antibody (Vector Laboratories). Band densitometry of the relative amounts of intact CCN-2 signal compared with degraded CCN-2 was undertaken for each sample lane in the Western immunoblots, as described previously (56) , with the signal in each lane serving as its own internal densitometric control. The densitometric bands analyzed were each within the linear (nonsaturated) range, enabling the semiquantitative analysis to be undertaken.
Tissue preparation and histological examination. Formalin-fixed adipose tissue was processed and embedded in paraffin for hematoxylin and eosin and immunohistochemistry for CCN-2. For immunohistochemical staining, sections (5 m) were cut and deparaffinized with xylene and rehydrated through graded ethanols. Antigen retrieval was done by heat treatment in a microwave for 2 min at 100°C in Tris-buffered saline (TBS; 100 mM Tris and 300 mM NaCl). Blocking of exogenous peroxidase activity was done by incubating slides with hydrogen peroxidase [1% (vol/vol) in methanol] for 20 min, followed by rinsing in TBS. Slides were then incubated with the in-house-generated primary anti-CCN-2 antibody (196, 1:100 dilution) (50, 56) . A biotin-conjugated goat anti-rabbit IgG secondary antibody (DAKO, Copenhagen, Denmark) was added, and the immunoreactive signal was detected using the Vectastain ABC kit (Vector Laboratories).
Table 1. List of primer sequences used in this study
Primer Sequence CTGF Forward 5=-GCA TCT CCA CCC GAG TTA-3= Reverse 5=-TTG ACA GGC TTG GCG ATT-3= Adiponectin Forward 5=-ATG ACG GCA GCA CTG GCA-3= Reverse 5=-CGG CCT TGT CCT TCT TGA-3= PPAR␥ Forward* 5=-CTG TCG GTT TCA GAA GTG CCT-3= Reverse* 5=-CCC AAA CCT GAT GGC ATT GTG AGA CA-3= TIMP-1 Forward* 5=-GGC ATC CTC TTG CTA TCA CTG-3= Reverse* 5=-GTC ATC TTG ATC TCA TAA CGC TGG-3= PAI-1 Forward* 5=-AGG GCT TCA TGC CCC ACT TCT TCA-3= Reverse* 5=-AGT AGA GGG CAT TCA CCA GCA CCA-3= 28S rRNA Forward* 5=-GTT CAC CCA CTA ATA GGG AAC GTG A-3= Reverse* 5=-GGA TTC TGA CTT AGA GGC GTT CAG T-3=
CTGF, connective tissue growth factor; PPAR␥, peroxisome proliferatoractivated receptor-␥; TIMP-1, tissue inhibitor metalloproteinase-1; PAI-1, plasminogen activator inhibitor type 1. Primers were designed to measure mouse CTGF, adiponectin, PPAR␥, TIMP-1, PAI-1, and 28S rRNA gene expression. *Sequences as accessed from Maquoi et al. (32) .
Determination of fat cell size. For these studies in fat tissue derived from mice euthanized at 24 wk, two sections ϳ50 m apart were selected, and the adipocyte cell size in three random fields in each section was determined. Because the cells were not uniformly round, the shortest length between the opposite cell membranes was measured routinely. For each cell, the intermembrane distance was measured by including the central point in the cell in these planar images (as adapted from Ref. 11) , where the lengths were measured in all of the complete cells within the field using Image Pro (www.mediacy. com; Media Cybernetics, Silver Spring, MD). Results were collated for each animal grouping.
Statistical analysis. All data were generated from groups of six to 10 animals and were expressed as means Ϯ SE. Parametric data were compared using unpaired t-tests or one-way ANOVA, followed by post hoc comparisons using Bonferroni's multiple comparison test or, if not normally distributed, by Mann-Whitney U-test. Correlation analysis was determined by simple linear regression analysis, and for all analysis statistical significance was accepted when P Ͻ 0.05.
RESULTS
The effect of HFD on animal characteristics. Animals were weighed at the start of the feeding protocol (week 0) and weekly thereafter until termination at either 15 or 24 wk. Mice fed the diet high in fat and fructose gained weight and were significantly heavier than chow-fed animals at 15 wk and 24 wk (Fig. 1, A and B, respectively). However, we observed that a significant minority of the mice (48% at 15 wk and 30% at 24 wk), despite access to only the HFD, failed to gain Ͼ5 g of weight (equal to the average weight gain of the chow-fed controls over the period of the study). For this reason, the HFD group was subdivided into two groups as follows: 1) mice with Ն5 g of gain in body weight (HFD-fat) and 2) mice with Ͻ5 g of gain in body weight (HFD-lean). Data for animal weights subdivided in this manner at 15 and 24 wk are shown in Fig. 1, C and D, respectively. From the commencement of the study, the control ND group gained 10.2 Ϯ 0.8 g at 15 wk and 11.8 Ϯ 0.6 g at 24 wk of feeding. After 15 wk of the HFD, the weight gainers (i.e., HFD-fat animals) gained 14.9 Ϯ 0.7 g, an average of 5 g more weight than the ND group (P Ͻ 0.001). At 24 wk, the HFD-fat group had gained 34.8 Ϯ 0.7 g, an average weight gain of 22 g, which was more than twice the amount gained by either the HFD-lean or ND group (12.5 Ϯ 0.4 and 11.8 Ϯ 0.6 g, respectively).
The effect of the diet on insulin sensitivity and on fat depot weights was also determined, and results are shown in Table 2 . The HFD resulted in greater weights for the epididymal and subcutaneous fat depots, which reached significance in the HFD-fat group by 15 wk of feeding (P Ͻ 0.05 for both depots). After 24 wk of HFD, the increase in fat pad weights was significant for all animals. The effect of the diet on liver weights was also examined and was not altered by the diet or its duration (Table 2 ). Also shown in Table 2 is the effect of the diet on insulin sensitivity, where feeding of a HFD for 15 wk did not alter insulin sensitivity in any of the high-fat-fed mice. However, after 24 wk of a HFD, the animals in the HFD-fat group were resistant to exogenous insulin, as seen by their significantly higher AUC compared with either the HFD-lean group (P Ͻ 0.01) or the ND group (P Ͻ 0.05).
High-fat feeding increases CCN-2 expression. The CCN-2 mRNA levels were measured in the epididymal and subcutaneous fat depots. Compared with ND animals, the expression of CCN-2 mRNA was increased significantly in both epididymal and subcutaneous fat depots at both 15 and 24 wk of dietary intervention (Fig. 2, A and B) . At 24 wk of HFD the magnitude of CCN-2 expression in the epididymal fat depot was greater than that seen at 15 wk (2-vs. 5-fold). This time-dependent induction of CCN-2 was not observed in the subcutaneous fat depot.
The data in the HFD were then analyzed according to the presence or absence of significant weight gain. When analyzed in this fashion, CCN-2 mRNA expression was induced in the epididymal fat pad only in those animals that gained Ͼ5 g body weight, i.e., the HFD-fat group (Fig. 2C) . The pattern seen in the subcutaneous fat depot was different from that seen for the epididymal fat; overall in this depot, the HFD induced CCN-2 expression irrespective of weight gain (Fig. 2D) . black bars) were weighed weekly, and the weight gain was determined at both 15 (A) and 24 wk (B) of dietary treatment. C and D: the mice in the HFD group were further subdivided into non-weight gainers (HFD-lean; gray bars) and weight gainers (HFD-fat; black bars), and the weight gain for both at 15 (C) and 24 wk (D) was determined. Each group is represented by at least 8 mice, and the data are expressed as means Ϯ SE. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, and ****P Ͻ 0.0001, significantly different across groups by unpaired t-test or 1-way ANOVA; Bonferroni's multiple comparison post hoc test.
High-fat feeding increases adipocyte size. The effect of HFD on fat cell size at 24 wk was analyzed as described, and the representative images and scored collated results are shown in Fig. 3, A-F and G-I, respectively. As shown, the average fat cell size increased in both epididymal and subcutaneous fat depots, but only in the HFD-fat animals (Fig. 3, C and F) , and the number of cells in each size range was similar for both fat depots (Fig. 3, H and I) . However, a significantly larger proportion of smaller-sized adipocytes was seen in the ND group for both fat depots (Fig. 3, A and  D) , and the fat depots from the HFD-fat group contained a larger number of adipocytes, with an average cell size diameter Ͼ75 m (Fig. 3G) . The average adipocyte cell size and distribution in the HFD-lean animals (Fig. 3, B and E) was similar to that seen in the ND group.
CCN-2 mRNA correlates with markers of adipocyte differentiation. The adipocyte differentiation status in epididymal fat and subcutaneous fat was then examined by measurement of the mRNA levels of the differentiation markers adiponectin and PPAR␥ (Fig. 4, A and B) . As shown, the pattern of expression of these markers was different in each of the fat depots. The epididymal adiponectin gene expression decreased with dietary duration, and in the subcutaneous fat it increased. There was no significant effect of the diet on the expression of PPAR␥ at either of the fat depots for either time point studied (Fig. 4, C and D) . Correlation analyses at week 24 of adiponectin and CCN-2 levels in animals fed the HFD (Fig.  4E) showed a highly significant correlation at the epididymal depot (P Ͻ 0.0001). There was also a strong positive correlation between epididymal CCN-2 and PPAR␥ levels (P Ͻ 0.01; Fig. 4F ). However, these correlations were not seen for the ND group or at the subcutaneous depot (for either of the adipocyte differentiation markers studied; data not shown).
CCN-2 mRNA correlates with genes involved in tissue turnover. The relationship between CCN-2 expression and other markers of Data expressed as means Ϯ SE; each group is represented by at least 8 mice. ND, normal chow diet; HFD, high-fat diet; HFD-lean, mice with Ͻ5 g of gain in body weight; HFD-fat, mice with Ն5 g of gain in body weight; AU, arbitrary units. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, significantly different from mice on ND; †P Ͻ 0.01 significantly different from non-weight gainers on HFD (HFD-lean) by 1-way ANOVA; Bonferroni's multiple comparison test. fat cell differentiation, particularly genes involved in tissue turnover (PAI-1 and TIMP-1), was then examined, and the results are shown in Fig. 5 . There was a weight gain-dependent increase in the expression of PAI-1 in both epididymal and subcutaneous fat depots, which was statistically significant at 24 wk (Fig. 5, A and  B) . Interestingly, the pattern of change of PAI-1 expression in the HFD-lean animals changed with duration of feeding, i.e., increasing at 15 wk but then returning to the same level as the ND animals at 24 wk. Correlation plots between CCN-2 and PAI-1 showed strong significant correlations at the epididymal (P Ͻ 0.01; Fig. 5C ) but not the subcutaneous depot in HFD-fat mice (Fig. 5D ). Epididymal TIMP-1 expression (Fig. 5E ) was increased in animals on HFD that gained weight and reached significance at 24 wk of dietary intervention (P Ͻ 0.01). The epididymal TIMP-1 levels in the HFD-lean group were similar to those of the ND group at both time points. No significant differences were seen in the subcutaneous TIMP-1 levels following high-fat feeding (Fig.  5F ). Interestingly, there was a strong correlation between epididymal CCN-2 and TIMP-1 levels (P Ͻ 0.001; Fig. 5G ) in the HFD-lean animals. No such correlations were observed in the HFD-fat group or for the subcutaneous fat depot (Fig. 5H) .
CCN-2 protein is degraded with high-fat feeding. The CCN-2 protein levels in the fat depots were then examined by Western immunoblot. For these studies, tissues from each fat depot of mice in the ND group and the HFD-fat group at the 24-wk time point were selected. Representative Western immunoblots of epididymal and subcutaneous fat are shown (Fig. 6, A and B,  respectively) , and quantitative data are given in Fig. 6 , C and Fig. 3 . Effect of high-fat feeding on adipocyte cell size. Representative hematoxylin and eosin images taken at ϫ400 magnification for both epididymal fat sites for ND (A), HFD-lean (B), and HFD-fat groups (C) and subcutaneous fat sites for ND (D), HFD-lean (E), and HFD-fat groups (F). G: average adipocyte cell size measured in ND (open bars), HFD-lean (gray bars), and HFD-fat animals (black bars). Relative proportion of cells/field graphed according to cell size in the epididymal (H) and subcutaneous fat depots (I). As described in RESULTS, the HFD-lean animals showed a leftward shift in the adipocyte size compared with the HFD-fat mice. Each group is represented by at least 8 mice, and the data are expressed as means Ϯ SE. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, significantly different across groups by 1-way ANOVA; Bonferroni's multiple comparison post hoc test.
D. There was a trend toward a decrease in the quantity of intact CCN-2 and a corresponding increase in the degraded form of CCN-2 in both the epididymal fat and subcutaneous fat depots of the HFD-fat group, which was significant for the subcutaneous fat depot (P Ͻ 0.05; Fig. 6D) .
As described previously, we found that CCN-2 was localized to adipocyte plasma membrane as well as the surrounding interstitium (55) . The localization and intensity of CCN-2 staining was then examined and the intensity of staining analyzed semiquantitatively in four different areas as follows: 1) overview of tissue section, 2) blood vessels, 3) adipocytes, and 4) the intensity of staining at small preadipocytes where applicable. Representative images and graphic results are shown in Fig. 7 . As shown, CCN-2 protein was associated with blood vessels and adipocytes. In epididymal tissue, the CCN-2 staining of preadipocytes (identified as those that were Ͻ50 m in diameter) was significantly greater in HFD animals compared with ND mice (Fig. 7, A, B, and E) . This CCN-2 pattern was not seen in subcutaneous tissue, which in contrast showed a general decrease in staining mainly surrounding blood vessels in the HFD mice (Fig. 7, C, D, and F) .
DISCUSSION
This study investigated the association between CCN-2 and adipocyte differentiation in fat tissue obtained from a dietaryinduced obesity murine model. Similar to other reported work, some animals fed the HFD did not gain weight (Ͻ55% increase from ND), and the weight gain of these mice were similar to animals fed the ND diet (12, 19, 39, 52) . The non-weight gainers in the HFD group formed approximately one-third of the animals fed a HFD and were analyzed as a separate entity (HFD-lean) to determine whether there were any molecular differences that could have been attributed to the lack of weight gain. HFD-fat animals were insulin resistant after 24 wk on the diet, and the weight of the epididymal and subcutaneous fat depots was significantly greater. In this group, the gene and protein expression of CCN-2 was increased and correlated with expression of adiponectin. CCN-2 has been implicated in the differentiation process based on our observations in vitro, and previously, we have shown a twofold increase in the expression of CCN-2 mRNA levels in epididymal fat compared with subcutaneous fat in animals fed standard laboratory chow (55). 5 . Effect of high-fat feeding on genes involved in tissue turnover [plasminogen activator inhibitor type 1 (PAI-1) and tissue inhibitor metalloproteinase-1 (TIMP-1)] and correlation with CCN-2. PAI-1 mRNA expression measured in epididymal (A) and subcutaneous fat depots (B). Correlation plots of CCN-2 and PAI-1 for the HFD group; HFD-lean (gray circles) and HFD-fat () in epididymal (C) and subcutaneous fat depots (D). TIMP-1 mRNA expression measured in epididymal (E) and subcutaneous fat depots (F). Correlation plots of CCN-2 and TIMP-1 in epididymal (G) and subcutaneous fat depots (H). Each group is represented by at least 8 mice, and the data are expressed as means Ϯ SE. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, significantly different across groups by 1-way ANOVA; Bonferroni's multiple comparison post hoc test. Correlation analysis was determined by simple linear regression, and the r 2 and P values are given within the graphs (HFD-lean, gray circles; HFD-fat, ).
This study provides for the first time evidence that CCN-2 mRNA is upregulated with high-fat feeding in both the epididymal and subcutaneous fat depots, with the greatest increase seen in the HFD-fat group, suggestive of a potential regulatory role of CCN-2 in adipocyte differentiation.
Increased adipose tissue mass can occur due to an increase in adipocyte hypertrophy, an increase in preadipocyte hyperplasia, or both of these changes (38, 48) . One characteristic feature of "insulin resistant" adipocytes is an increase in adipocyte cell size (29, 47, 48) . Analysis of the adipocyte cell size showed that, as expected, the average size of the adipocytes in the HFD group was significantly larger than in the ND mice, a result reported previously by others in similar rodent models of dietary-induced obesity (22, 29, 35, 44) . Compared with the HFD-lean group, the relative distribution of adipocytes according to size was similar to that of the ND group, whereas the HFD-fat group showed a higher proportion of larger-sized adipocytes. Moreover, in a recent study of human adipocytes in vitro, there were strong linear correlations over time for the secretion of adipokines with increase in adipocyte size, suggesting that adipocyte size is an important determinant of adipokine secretion (47) .
Consistent with the total body insulin resistance and the degree of adipocyte hyperplasia and hypertrophy found in the HFD-fat group, the expression of several adipocyte differentiation markers, especially in the gonadal-associated (epididymal) fat depot, shows a picture suggestive of decreased differentiation of adipocytes. In particular, the gene expression of adiponectin, an insulin-sensitizing adipocytokine, was reduced significantly in HFD-fat animals compared with their ND counterparts despite having increased body and corresponding fat pad weights in both depots. The reduction in adiponectin reflects that the HFD-fat animals were less responsive to insulin, as highlighted by the insulin tolerance test. The strong correlation seen between higher levels of CCN-2 combined with the reduction in adiponectin levels in the epididymal fat depots highlights the potential role of CCN-2 in a "counterregulatory" way, inhibiting the adipocyte differentiation program, complementing our earlier in vitro findings (55) . No significant changes were seen in the expression of PPAR␥, but this could be attributed to this adipogenesis transcription factor being induced at very early stages of disease progression (21, 64) . We have observed that CCN-2 inhibits adiponectin and PPAR␥ mRNA levels and differentiation in vitro (55) . It is likely that PPAR␥ itself does not positively regulate CCN-2 mRNA but that a program of fat cell differentiation occurring at that site can induce CCN-2 mRNA, and then, on the basis of the in vitro data, the induced CCN-2 may serve to limit the extent of fat cell differentiation. To further define this relationship, intervention studies targeting fat depots involving CCN-2 will be required.
The expression of certain key genes involved in tissue turnover were also studied, particularly PAI-1, a known adipocytokine with established links to inflammation and obesity (31, 37, 46) , and TIMP-1, an established negative regulator of adipogenesis (10, 34) . The high PAI-1 mRNA expression in HFD-fat animals was indicative of an inflammatory state, which in itself could result in a cascade of other inflammatory factors. These observations were consistent with other studies of dietary-induced models of obesity, where the adiponectin mRNA expression was significantly lower in the obese mice (13, 40) , but these mice had a higher PAI-1 mRNA expression (45, 46) . Furthermore, correlation studies in the current work have highlighted strong links between CCN-2 and PAI-1 at both epididymal and subcutaneous fat depots, suggesting that CCN-2 plays a role in the progression of dietary-induced obesity, a mild chronic inflammatory disease. Extracellular matrix reorganization is a critical step in the adipocyte differentiation process, with TIMP-1 being a key mediator both in vitro and in vivo (10, 26, 32, 55) . This study confirms these observations where an increase in epididymal TIMP-1 was seen in the HFD-fat group. Studies in mesangial cells have highlighted a link between CCN-2 and TIMP-1 (33), which is indicative of the potential of CCN-2 to affect the MMP/TIMP balance for the regulation of extracellular matrix. Our correlation studies have confirmed this link at the epididymal adipose sites, implicating a link between CCN-2 and TIMP-1 and their subsequent role in inhibiting the differentiation of adipocytes in vivo.
Protein expression of CCN-2 was also measured in this work using an antibody specific for the fourth (carboxy-terminal) module of CCN-2; both intact and degraded CCN-2 were detected. There was an increase in the concentration of a lower-molecular-mass (likely degraded) CCN-2 protein at both the epididymal and subcutaneous fat depots in the fat-fed animals, suggesting that the turnover and degradation of CCN-2 protein is increased in these mice. Several reports by others have documented the presence of low-molecular-weight degraded forms of CCN-2 protein that represent proteolytic fragments of the full-length molecule, varying in size from 10 to 20 kDa and constituting mainly module 4 either alone or in combination with module 3 of CCN-2 (4, 7, 43, 50, 63) .
Several of these isoforms are biologically active and stimulate mitosis and cell adhesion, indicating that the carboxy-terminal region contains functional domains that mediate several activities of CCN-2 (7, 51) . Immunohistochemical detection of CCN-2 showed that the smaller cells or preadipocytes in the epididymal site had high CCN-2 immunoreactivity. These cells were in nests, and the immunoreactivity increase could be within the cell/plasma membrane and/or in the surrounding extracellular matrix. These adipocytes could be either newly forming adipocytes or potentially dedifferentiating mature adipocytes. In both situations, CCN-2 protein would be projected to be high. However, they were not commonly seen in the sections, and they would form Ͻ10% of the total fat cell complement, explaining why the total CCN-2 levels at Western immunoblot of whole cell lysate did not show increased CCN-2 protein in the HFD animals at the epididymal site. Future studies investigating the bioactivity of the various forms of CCN-2 and CCN-2 turnover rate could help to further elucidate its role and dynamic regulation in adipocyte differentiation.
In our previous work addressing CCN-2 effects and expression in adipose cells in vitro, addition of exogenous CCN-2 was found to inhibit adipocyte differentiation, and CCN-2 mRNA steady-state levels fell as murine adipogenesis progressed (55) . Consistent with those findings, others have reported recently that CCN-2 expression in human peripheral Fig. 7 . Representative images of CCN-2 immunohistochemical localization at ϫ400 magnification for both epididymal fat sites for ND (A) and HFD groups (B) and subcutaneous fat sites for ND (C) and HFD groups (D). Scoring of CCN-2 immunohistochemical staining according to 4 categories: overview of tissue section, blood vessels, adipocytes, and small adipocytes (where applicable) in epididymal (E) and subcutaneous fat depots (F). Results are expressed as means Ϯ SE, and the data are derived from 6 mice/group, with a total of 2 sections/mouse. *P Ͻ 0.05, significantly different from mice on ND, using multiple Mann-Whitney U-tests; ND compared with HFD across the 4 different regions.
adipose tissue organ cultures is inhibited by administration of the proadipogenic agent troglitazone and also that proinflammatory cytokines IL-1␤ and TNF␣ induce CCN-2 (17) . The finding in the current work that CCN-2 correlates positively with adipose tissue amount and body weight gain in wild-type mice fed HFD ad libitum is in accord with the concept that CCN-2 may inhibit the fat cell differentiation program and link to inflammation in adipose tissue and insulin resistance. Studies of CCN-2 regulation in vivo will be required to determine whether it is a marker alone or possibly also a mediator in adipogenesis, insulin sensitivity, and body fat amount and distribution.
Adipose CCN-2 mRNA levels were found to be differentially regulated in the HFD-lean group of animals compared with the HFD-fat mice. First, at week 15, CCN-2 mRNA levels were significantly upregulated in the HFD-lean mice in the subcutaneous site. These findings were very similar to those seen for PAI-1 (Fig. 5B) . Second, that CCN-2 mRNA levels in epididymal fat at 24 wk in HFD-lean mice were lower compared with HFD-fat fed mice is an intriguing finding; at that time point the CCN-2 mRNA levels in normal chow-fed mice were very low, less than controls (albeit nonsignificantly; Fig.  2C ). In contrast, the TIMP-1 data show no such differential regulation in the HFD-lean compared with HFD-fat groups. Collectively, the relative CCN-2 mRNA data at subcutaneous and epididymal fat pad sites across these two time points cosegregate with a resistance to diet-induced obesity, with a relatively higher level of CCN-2 mRNA at subcutaneous sites being associated with lesser propensity to weight gain. Again, studies directly targeting CCN-2 regulation in vivo will be required to determine whether it is a marker alone or possibly also a mediator in adipogenesis, insulin sensitivity, and body fat amount and distribution.
In summary, we report the novel finding that CCN-2 mRNA is upregulated with high-fat feeding in both epididymal and subcutaneous sites, indicating that CCN-2 may influence the degree of adipocyte differentiation and thus the formation of insulin-resistant adipocytes. This is supported by the observation that CCN-2 mRNA is most upregulated in the gonadalassociated (epididymal) rather than the subcutaneous site in fat-fed animals. In addition, in the animals that gained the most body weight on the fat-fed diet, CCN-2 mRNA levels were highest. Across all animals studied, CCN-2 mRNA correlated positively with adipocyte cell size and key genes involved in adipocyte differentiation (adiponectin and PPAR␥) and tissue turnover (PAI-1 and TIMP-1). There was also an increase in the proportion of degraded CCN-2 protein at both fat depots of the fat-fed animals, which could suggest increased protein turnover and degradation in these mice and could affect several biological actions. CCN-2 was colocalized mainly with the smaller adipocytes, which may be either the least differentiated and/or dedifferentiated cells. More studies specifically impacting on the regulation of this putative pathway will be required in vivo to address whether this linear pathway occurs. It would also be of interest to determine whether a similar regulation is seen in humans by observing the regulation of CCN-2 in tissue explants of subcutaneous and visceral fat. In addition, exploring the effects of CCN-2 in vivo by generating regulation studies involving knockdown or overexpression of CCN-2 in a mouse model would further complement the novel findings of this work.
